Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 301 participants.

Also called NCT05513937

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 301 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05513937
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Bulgaria (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05513937. Non-randomized; no masking; primary purpose treatment. Start 2022-05-12 (actual); primary completion 2022-11-15 (actual). Results posted on 2025-02-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
Acronym
Botticelli
Condition
Hypertension
Intervention (Drug)
Nebivolol
Intervention (Drug)
Amlodipine
Lead sponsor
Menarini International Operations Luxembourg SA (class: industry)

Record details

Record id
cardio:ct-nct05513937
Content hash
f0754d0cb5dec2e908bd19a5c8bdad82ea6abf555de33c40faf60fc0026cd66d